277 related articles for article (PubMed ID: 19492151)
1. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.
Hammerstingl C; Omran H;
Thromb Haemost; 2009 Jun; 101(6):1085-90. PubMed ID: 19492151
[TBL] [Abstract][Full Text] [Related]
2. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
Hammerstingl C; Omran H
Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
[TBL] [Abstract][Full Text] [Related]
3. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
4. Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry.
Hammerstingl C; Schmitz A; Fimmers R; Omran H
Cardiovasc Ther; 2009; 27(4):230-8. PubMed ID: 19903186
[TBL] [Abstract][Full Text] [Related]
5. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
6. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
[TBL] [Abstract][Full Text] [Related]
7. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
Hammerstingl C; Omran H; Tripp C; Poetzsch B
Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817
[TBL] [Abstract][Full Text] [Related]
8. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
9. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
11. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
12. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
13. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
Klamroth R; Gottstein S; Essers E; Landgraf H
Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
[TBL] [Abstract][Full Text] [Related]
14. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
Weiss A; Brose S; Ploetze K; Matschke K
Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
16. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin outcomes in patients with moderate renal impairment.
DeCarolis DD; Thorson JG; Clairmont MA; Leuthner AM; Rector TS; Johnson GJ
Arch Intern Med; 2012 Dec; 172(22):1713-8. PubMed ID: 23128835
[TBL] [Abstract][Full Text] [Related]
18. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
[TBL] [Abstract][Full Text] [Related]
19. Enoxaparin as bridging anticoagulant treatment in cardiac surgery.
Rivas-Gándara N; Ferreira-González I; Tornos P; Torrents A; Permanyer-Miralda G; Nicolau I; Arellano-Rodrigo E; Vallejo N; Igual A; Soler-Soler J
Heart; 2008 Feb; 94(2):205-10. PubMed ID: 17483131
[TBL] [Abstract][Full Text] [Related]
20. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry.
Hammerstingl C; Tripp C; Schmidt H; von der Recke G; Omran H
J Heart Valve Dis; 2007 May; 16(3):285-92. PubMed ID: 17578050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
